Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akebia Therapeutics (AKBA) Non-cash Items: 2016-2019

Historic Non-cash Items for Akebia Therapeutics (AKBA) over the last 4 years, with Dec 2019 value amounting to $3.8 million.

  • Akebia Therapeutics' Non-cash Items rose 59.87% to $3.8 million in Q4 2019 from the same period last year, while for Dec 2019 it was $3.8 million, marking a year-over-year increase of 59.87%. This contributed to the annual value of $3.8 million for FY2019, which is 59.87% up from last year.
  • According to the latest figures from FY2019, Akebia Therapeutics' Non-cash Items is $3.8 million, which was up 59.87% from $2.4 million recorded in FY2018.
  • Akebia Therapeutics' 5-year Non-cash Items high stood at $21.9 million for FY2017, and its period low was $1.1 million during FY2016.
  • In the last 3 years, Akebia Therapeutics' Non-cash Items had a median value of $3.8 million in 2019 and averaged $9.3 million.
  • Per our database at Business Quant, Akebia Therapeutics' Non-cash Items skyrocketed by 1,832.63% in 2017 and then tumbled by 89.28% in 2018.
  • Akebia Therapeutics' Non-cash Items (Yearly) stood at $1.1 million in 2016, then spiked by 1,832.63% to $21.9 million in 2017, then slumped by 89.28% to $2.4 million in 2018, then surged by 59.87% to $3.8 million in 2019.